Jeil Pharmaceutical Co Ltd (271980) — Cash Flow Quality Index
Jeil Pharmaceutical Co Ltd (271980) has a Cash Flow Quality Index of 1.29x as of September 2025. Operating cash flow of ₩13.23 Billion exceeds net income of ₩10.28 Billion, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of Jeil Pharmaceutical Co Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jeil Pharmaceutical Co Ltd Cash Flow Quality Index (2017–2023)
Historical Cash Flow Quality Index for Jeil Pharmaceutical Co Ltd across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Jeil Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Jeil Pharmaceutical Co Ltd (2017–2023)
Year-by-year earnings quality comparison for Jeil Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 271980 company net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -1.00x | ₩-4.98 Billion | ₩5.00 Billion | ▲ +63.9% |
| 2020 | -2.75x | ₩-19.05 Billion | ₩6.92 Billion | ▼ -124.2% |
| 2018 | 11.36x | ₩21.45 Billion | ₩1.89 Billion | ▲ +388.0% |
| 2017 | -3.94x | ₩-4.21 Billion | ₩1.07 Billion | — |